Application Information

This drug has been submitted to the FDA under the reference 022198/001.

Names and composition

"SANCUSO" is the commercial name of a drug composed of GRANISETRON.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022198/001 SANCUSO GRANISETRON FILM, EXTENDED RELEASE/TRANSDERMAL 3.1MG per 24HR

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022198/001 SANCUSO GRANISETRON FILM, EXTENDED RELEASE/TRANSDERMAL 3.1MG per 24HR
022445/001 SUSTOL GRANISETRON INJECTION, EXTENDED RELEASE/SUBCUTANEOUS 10MG per 0.4ML (10MG per 0.4ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved